Expression Table for this CRE
| CNhs14417 | 293SLAM rinderpest infection, 24hr, biol_rep2 | 14.0 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 9.3 |
| CNhs14078 | amygdala, newborn, donor10223 | 6.3 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 4.7 |
| CNhs13835 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 1.8 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 1.6 |
| CNhs10610 | SABiosciences XpressRef Human Universal Total RNA, pool1 | 1.5 |
| CNhs14058 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 1.3 |
| CNhs11834 | carcinoid cell line:NCI-H1770 | 1.2 |
| CNhs13836 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 1.1 |
| CNhs12363 | mesenchymal precursor cell - adipose, donor1 | 1.1 |
| CNhs11835 | osteoclastoma cell line:Hs 706.T | 1.0 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 0.9 |
| CNhs13919 | CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 0.9 |
| SRX6586328 | CNhi10316_MCF-7_Simvastatin-30 uM-6h_rep1 | 0.9 |
| CNhs12035 | Osteoblast - differentiated, donor3 | 0.8 |
| CNhs13345 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 0.8 |
| CNhs13202 | CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1 | 0.8 |
| SRX6586324 | CNhi10316_MCF-7_Atrovastatin-30 uM-6h_rep3 | 0.8 |
| CNhs12873 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13) | 0.8 |
| CNhs13204 | CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1 | 0.8 |
| SRX6586366 | CNhi10369_MCF-7_siRNA-negative control-48h_rep2 | 0.8 |
| CNhs13049 | acute myeloid leukemia (FAB M7) cell line:M-MOK | 0.7 |
| CNhs10621 | heart, adult, pool1 | 0.6 |
| SRX6586322 | CNhi10315_MCF-7_Non-treatment (DMSO)-6h_rep6 | 0.6 |
| SRX6586327 | CNhi10316_MCF-7_Fluvastatin-30 uM-6h_rep3 | 0.6 |
| CNhs13842 | iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2 | 0.6 |
| CNhs12690 | K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 0.6 |
| SRX6586323 | CNhi10316_MCF-7_Atrovastatin-30 uM-6h_rep2 | 0.5 |
| SRX6586325 | CNhi10316_MCF-7_Fluvastatin-30 uM-6h_rep1 | 0.5 |
| CNhs11985 | Smooth Muscle Cells - Brachiocephalic, donor2 | 0.5 |
| SRX9760355 | skeletal muscle_prior_exercise (Individual 2) | 0.5 |
| CNhs13367 | Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 0.5 |
| SRX6586289 | CNhi10324_HepG2_Atrovastatin-30 uM-48h_rep2 | 0.5 |
| SRX6586329 | CNhi10316_MCF-7_Simvastatin-30 uM-6h_rep2 | 0.5 |
| SRX6586326 | CNhi10316_MCF-7_Fluvastatin-30 uM-6h_rep2 | 0.5 |
| CNhs13361 | Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 0.4 |
| CNhs14487 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 0.4 |
| LShi10030_ACTTGA-CACTAGT | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep2 | 0.4 |
| CNhs11734 | small-cell gastrointestinal carcinoma cell line:ECC4 | 0.4 |
| CNhs10634 | thyroid, adult, pool1 | 0.4 |
| CNhs12088 | Renal Epithelial Cells, donor2 | 0.4 |
| CNhs13851 | Myoblast differentiation to myotubes, day04, control donor1 | 0.3 |
| CNhs14594 | Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 0.3 |
| CNhs13603 | mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 0.3 |
| SRX4504741 | human NET-CAGE MCF-7, response to HRG, 60 min, biol_rep2 | 0.3 |
| CNhs11903 | Gingival epithelial cells, donor3 (GEA15) | 0.3 |
| CNhs10643 | occipital pole, adult, pool1 | 0.3 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 0.3 |
| CNhs12582 | Fibroblast - skin normal, donor2 (nuclear fraction) | 0.3 |